Sigilon Therapeutics, Inc. Gross Margin 2021-2023 | SGTX
Current and historical gross margin for Sigilon Therapeutics, Inc. (SGTX) over the last 10 years. The current gross profit margin for Sigilon Therapeutics, Inc. as of June 30, 2023 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-06-30 | $0.02B | $0.02B | 100.00% |
| 2023-03-31 | $0.02B | $0.02B | 100.00% |
| 2022-12-31 | $0.01B | $0.01B | 100.00% |
| 2022-09-30 | $0.01B | $0.01B | 100.00% |
| 2022-06-30 | $0.01B | $0.01B | 100.00% |
| 2022-03-31 | $0.01B | $0.01B | 100.00% |
| 2021-12-31 | $0.01B | $0.01B | 100.00% |
| 2021-09-30 | $0.01B | $0.01B | 100.00% |
| 2021-06-30 | $0.01B | $0.01B | 100.00% |
| 2021-03-31 | $0.01B | $0.01B | 100.00% |
| 2020-12-31 | $0.01B | $0.01B | 100.00% |
